Pfizer Said to Fire 20% of U.S. Primary-Care Sales Force
This article is for subscribers only.
Pfizer Inc., the company that lost its patent a year ago on the top-selling drug Lipitor, is firing almost 20 percent of its roughly 3,000-person sales force for primary-care drugs, said a person familiar with the matter.
The cuts, about 600 positions, are to begin this month and are part of the New York-based company’s continuing effort to lower costs, said the person, who asked not to be named because they weren’t authorized to discuss the matter publicly.